ShockWave Medical (SWAV)
(Delayed Data from NSDQ)
$328.87 USD
+0.33 (0.10%)
Updated Apr 24, 2024 04:00 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Shockwave Medical (SWAV) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$306.70 | $368.00 | $210.00 | -6.74% |
Price Target
Based on short-term price targets offered by 10 analysts, the average price target for Shockwave Medical comes to $306.70. The forecasts range from a low of $210.00 to a high of $368.00. The average price target represents a decline of 6.74% from the last closing price of $328.87.
Analyst Price Targets (10)
Broker Rating
Shockwave Medical currently has an average brokerage recommendation (ABR) of 2.82 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 11 brokerage firms. The current ABR compares to an ABR of 1.91 a month ago based on 11 recommendations.
Of the 11 recommendations deriving the current ABR, one is Strong Buy, representing 9.09% of all recommendations. A month ago, Strong Buy made up 54.55%, while Buy represented 18.18%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 6 | 6 | 6 |
Buy | 0 | 0 | 2 | 1 | 1 |
Hold | 10 | 10 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 1 | 1 | 1 |
ABR | 2.82 | 2.82 | 1.91 | 1.90 | 1.90 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/8/2024 | C.L. King & Associates | Kristen M Stewart | Moderate Buy | Hold |
4/8/2024 | SVB Securities | Michael Kratky | Hold | Hold |
4/5/2024 | Needham & Company | Michael Matson | Moderate Buy | Hold |
4/5/2024 | Piper Sandler | Adam C Maeder | Strong Buy | Hold |
4/5/2024 | Canaccord Genuity | William J Plovanic | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.82 |
ABR (Last week) | 2.82 |
# of Recs in ABR | 11 |
Average Target Price | $306.70 |
LT Growth Rate | 27.20% |
Industry | Medical - Instruments |
Industry Rank by ABR | 87 of 252 |
Current Quarter EPS Est: | 1.04 |